PMID: 25775837Mar 18, 2015Paper

Repeated computed tomography examinations: radiation dose and radiation risk in malignant lymphomas

Radiatsionnaia biologiia, radioecologiia
S A Kharuzhyk, E A Leusik

Abstract

The aim of the study was to determine the number, types and time periods of computed tomography (CT) examinations in the patients with lymphomas, to estimate the obtained radiation doses and the attributable risk of cancer. 50 patients aged 18-83 years, 25 men and 25 women who received treatment in 2010-2011 were included in a retrospective study. There were 19 patients with Hodgkin Disease and 31 patients with Non-Hodgkin's Lymphoma. During the monitoring period there 665 CT examinations were conducted including 169 (25%) prior to treatment, 244 (37%) during chemotherapy, 54 (8%) for radiation therapy planning and 198 (30%) after end of treatment. The average number of CT examinations per patient was 13.3 (range 3-29). 32 (64%) patients underwent 10 and more CTs, 10 (20%) patients--20 and more. The most commonly performed examination was CT of the chest. Number of CT controls after treatment per patient averaged 2.7 (range 1-6). The mean effective dose per patient was 86.7 mSv (range 21.7-209.2 mSv). 37 (74%) patients received more than 50 mSv during the entire period, 14 (28%) patients--more than 100 mSv, 6(12%) patients--more than 150 mSv and 1 (2%) patient--more than 200 mSv.6 (12%) patients received more than 100 mSv durin...Continue Reading

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.